Intended for healthcare professionals
Search
Toggle navigation
Current issue
Archive
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Editorial board
For authors
Advertising
Contact us
News
Web Exclusives
Register
FREE
Sign in
×
Remember me
Not registered?
Forgot your password?
A spot of Savin: Can we beat pemphigus?
John Savin
If you read only one scientific paper this year, make it the one listed below – by Proby
et al.
It contains a strikingly original idea on how to deal with pemphigus. Admittedly you may find the paper fairly hard work; one sentence in the summary, for example, runs: ‘The epitopes of these monoclonal antibodies were mapped on the amino terminal EC1 and part of EC2, a region considered functionally important in cadherins’. Your best plan is probably to read first the commentary on the paper that the editors of the
British Journal of Dermatology
have thoughtfully provided. If you find this difficult too, then simply plough on to the end of this page.
Dermatology in practice
2000;
8
(3): 31–31
To continue reading this article, please
sign in
or
register
.
Follow us on
|
|
Latest News
J&J presents positive phase 3b results for Tremfya in plaque psoriasis
Bristol Myers Squibb shares positive phase 3b/4 results for Sotyktu in scalp psoriasis
Eli Lilly/Almirall announce long-term results for IL-13 inhibitor Ebglyss in atopic dermatitis
LEO Pharma’s Anzupgo cream granted EC approval in chronic hand eczema
UCB announces two-year data for Bimzelx in hidradenitis suppurativa
This site uses cookies in order to function properly and to allow us to improve our service. By using this site you consent to the use of cookies as set out in our
privacy policy